NCT07259213 2026-03-12
RAD402
Radiopharm Theranostics, Ltd
Phase 1/2 Recruiting
Clinical Trials
8 trialsNCT02669771 2024-11-21
Long-Term Specified Drug Use-Results Survey for Xtandi Capsule
Astellas Pharma Inc
Completed
NCT04232761 2024-07-17
RAPIT
Bayer
Completed
NCT06227156 2024-05-23
Disitamab Vedotin in the Treatment With HER2- Expression, Subjects With Locally Advanced or Metastatic Castration-resistant Prostate Cancer
RemeGen Co., Ltd.
Phase 2 Recruiting
NCT04962880 2023-04-14
PROSPECT
AstraZeneca
Completed
NCT03514836 2021-02-01
A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer
Sotio Biotech Inc.
Phase 1/2 Terminated
NCT01634061 2020-12-09
Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients
Novartis
Phase 1 Completed
NCT02361086 2019-02-01
A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer
Innocrin Pharmaceutical
Phase 1/2 Completed